703 related articles for article (PubMed ID: 31158081)
1. Optimizing the Number of Cores Targeted During Prostate Magnetic Resonance Imaging Fusion Target Biopsy.
Kenigsberg AP; Renson A; Rosenkrantz AB; Huang R; Wysock JS; Taneja SS; Bjurlin MA
Eur Urol Oncol; 2018 Oct; 1(5):418-425. PubMed ID: 31158081
[TBL] [Abstract][Full Text] [Related]
2. The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsy.
Cash H; Maxeiner A; Stephan C; Fischer T; Durmus T; Holzmann J; Asbach P; Haas M; Hinz S; Neymeyer J; Miller K; Günzel K; Kempkensteffen C
World J Urol; 2016 Apr; 34(4):525-32. PubMed ID: 26293117
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit.
Radtke JP; Takhar M; Bonekamp D; Kesch C; Erho N; du Plessis M; Buerki C; Ong K; Davicioni E; Hohenfellner M; Hadaschik BA
Eur Urol Focus; 2018 Jul; 4(4):540-546. PubMed ID: 28753844
[TBL] [Abstract][Full Text] [Related]
4. The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion Biopsy.
Patel N; Cricco-Lizza E; Kasabwala K; Xu C; Robinson BD; Khani F; Wang Y; Margolis D; Hu JC
Eur Urol Oncol; 2018 Sep; 1(4):263-267. PubMed ID: 31100246
[TBL] [Abstract][Full Text] [Related]
5. Role of Core Number and Location in Targeted Magnetic Resonance Imaging-Ultrasound Fusion Prostate Biopsy.
Lu AJ; Syed JS; Ghabili K; Hsiang WR; Nguyen KA; Leapman MS; Sprenkle PC
Eur Urol; 2019 Jul; 76(1):14-17. PubMed ID: 31047733
[TBL] [Abstract][Full Text] [Related]
6. How Many Targeted Biopsy Cores are Needed for Clinically Significant Prostate Cancer Detection during Transperineal Magnetic Resonance Imaging Ultrasound Fusion Biopsy?
Song G; Ruan M; Wang H; Fan Y; He Q; Lin Z; Li X; Li P; Wang X; He Z; Zhou L
J Urol; 2020 Dec; 204(6):1202-1208. PubMed ID: 32716686
[TBL] [Abstract][Full Text] [Related]
7. Analysis of histological findings obtained combining US/mp-MRI fusion-guided biopsies with systematic US biopsies: mp-MRI role in prostate cancer detection and false negative.
Faiella E; Santucci D; Greco F; Frauenfelder G; Giacobbe V; Muto G; Zobel BB; Grasso RF
Radiol Med; 2018 Feb; 123(2):143-152. PubMed ID: 29019021
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy-Are 2 Biopsy Cores per Magnetic Resonance Imaging Lesion Required?
Dimitroulis P; Rabenalt R; Nini A; Hiester A; Esposito I; Schimmöller L; Antoch G; Albers P; Arsov C
J Urol; 2018 Nov; 200(5):1030-1034. PubMed ID: 29733837
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance.
Radtke JP; Kuru TH; Boxler S; Alt CD; Popeneciu IV; Huettenbrink C; Klein T; Steinemann S; Bergstraesser C; Roethke M; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2015 Jan; 193(1):87-94. PubMed ID: 25079939
[TBL] [Abstract][Full Text] [Related]
10. The Institutional Learning Curve of Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy: Temporal Improvements in Cancer Detection in 4 Years.
Meng X; Rosenkrantz AB; Huang R; Deng FM; Wysock JS; Bjurlin MA; Huang WC; Lepor H; Taneja SS
J Urol; 2018 Nov; 200(5):1022-1029. PubMed ID: 29886090
[TBL] [Abstract][Full Text] [Related]
11. Anterior Localization of Prostate Cancer Suspicious Lesions in 1,161 Patients Undergoing Magnetic Resonance Imaging/Ultrasound Fusion Guided Targeted Biopsies.
Leyh-Bannurah SR; Kachanov M; Beyersdorff D; Preisser F; Tilki D; Fisch M; Graefen M; Budäus L
J Urol; 2018 Nov; 200(5):1035-1040. PubMed ID: 29935274
[TBL] [Abstract][Full Text] [Related]
12. MRI/US fusion-guided prostate biopsy allows for equivalent cancer detection with significantly fewer needle cores in biopsy-naive men.
Yarlagadda VK; Lai WS; Gordetsky JB; Porter KK; Nix JW; Thomas JV; Rais-Bahrami S
Diagn Interv Radiol; 2018; 24(3):115-120. PubMed ID: 29770762
[TBL] [Abstract][Full Text] [Related]
13. Risk of Prostate Cancer after a Negative Magnetic Resonance Imaging Guided Biopsy.
Kinnaird A; Sharma V; Chuang R; Priester A; Tran E; Barsa DE; Delfin M; Kwan L; Sisk A; Felker E; Marks LS
J Urol; 2020 Dec; 204(6):1180-1186. PubMed ID: 32614257
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of Transperineal Targeted Prostate Biopsies, Visual Estimation and Image Fusion in Men Needing Repeat Biopsy in the PICTURE Trial.
Simmons LAM; Kanthabalan A; Arya M; Briggs T; Barratt D; Charman SC; Freeman A; Hawkes D; Hu Y; Jameson C; McCartan N; Moore CM; Punwani S; van der Muelen J; Emberton M; Ahmed HU
J Urol; 2018 Dec; 200(6):1227-1234. PubMed ID: 30017964
[TBL] [Abstract][Full Text] [Related]
15. Primary magnetic resonance imaging/ultrasonography fusion-guided biopsy of the prostate.
Maxeiner A; Kittner B; Blobel C; Wiemer L; Hofbauer SL; Fischer T; Asbach P; Haas M; Penzkofer T; Fuller F; Miller K; Cash H
BJU Int; 2018 Aug; 122(2):211-218. PubMed ID: 29569320
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Initial Experience with Transrectal Magnetic Resonance Imaging Cognitive Guided Micro-Ultrasound Biopsies versus Established Transperineal Robotic Ultrasound Magnetic Resonance Imaging Fusion Biopsies for Prostate Cancer.
Claros OR; Tourinho-Barbosa RR; Fregeville A; Gallardo AC; Muttin F; Carneiro A; Stabile A; Moschini M; Macek P; Cathala N; Mombet A; Sanchez-Salas R; Cathelineau X
J Urol; 2020 May; 203(5):918-925. PubMed ID: 31821099
[TBL] [Abstract][Full Text] [Related]
17. Is it Time to Perform Only Magnetic Resonance Imaging Targeted Cores? Our Experience with 1,032 Men Who Underwent Prostate Biopsy.
Pepe P; Garufi A; Priolo GD; Galia A; Fraggetta F; Pennisi M
J Urol; 2018 Oct; 200(4):774-778. PubMed ID: 29679618
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of elastic fusion biopsy in daily practice: Results of a multicenter study of 2115 patients.
Oderda M; Marra G; Albisinni S; Altobelli E; Baco E; Beatrici V; Cantiani A; Carbone A; Ciccariello M; Descotes JL; Dubreuil-Chambardel M; Eldred-Evans D; Fasolis G; Ferriero M; Fiard G; Forte V; Giacobbe A; Kumar P; Lacetera V; Mozer P; Muto G; Papalia R; Pastore A; Peltier A; Piechaud T; Simone G; Roche JB; Roupret M; Rouviere O; Van Velthoven R; Gontero P
Int J Urol; 2018 Dec; 25(12):990-997. PubMed ID: 30187529
[TBL] [Abstract][Full Text] [Related]
19. Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators.
Alberts AR; Roobol MJ; Verbeek JFM; Schoots IG; Chiu PK; Osses DF; Tijsterman JD; Beerlage HP; Mannaerts CK; Schimmöller L; Albers P; Arsov C
Eur Urol; 2019 Feb; 75(2):310-318. PubMed ID: 30082150
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of real-time magnetic resonance imaging-transrectal ultrasound fusion image-guided transperineal target biopsy with needle tracking with a mechanical position-encoded stepper in detecting significant prostate cancer in biopsy-naïve men.
Shoji S; Hiraiwa S; Ogawa T; Kawakami M; Nakano M; Hashida K; Sato Y; Hasebe T; Uchida T; Tajiri T
Int J Urol; 2017 Apr; 24(4):288-294. PubMed ID: 28222486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
